From: PMS2 mutation spectra in Norway and risk of cancer for carriers of pathogenic variants
Age cohort
PMS2 carriers (n = 87)
> 30
2 (2.3%)
30–39
8 (9.2%)
40–49
24 (27.5%)
50–59
23 (26.4%)
60–69
18 (20.7%)
70-
12 (13.8%)